Catherine Schulte
Stock Analyst at Baird
(4.37)
# 347
Out of 5,078 analysts
142
Total ratings
61.67%
Success rate
13.36%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $142 → $165 | $148.81 | +10.88% | 18 | Nov 25, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $72 → $88 | $101.20 | -13.04% | 15 | Nov 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $15 → $17 | $11.64 | +46.05% | 14 | Oct 24, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,447.16 | -15.01% | 10 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $580.37 | -2.30% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $226.59 | +1.06% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $3.44 | -41.86% | 6 | May 13, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $42 → $43 | $46.94 | -8.39% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $62.95 | +8.02% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $39.11 | -2.84% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $29.70 | +11.11% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $127.55 | +120.31% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $398.62 | -45.56% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $236.64 | -91.55% | 1 | Jun 28, 2018 |
Agilent Technologies
Nov 25, 2025
Maintains: Outperform
Price Target: $142 → $165
Current: $148.81
Upside: +10.88%
Exact Sciences
Nov 4, 2025
Maintains: Outperform
Price Target: $72 → $88
Current: $101.20
Upside: -13.04%
Avantor
Oct 24, 2025
Maintains: Outperform
Price Target: $15 → $17
Current: $11.64
Upside: +46.05%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,447.16
Upside: -15.01%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $580.37
Upside: -2.30%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $226.59
Upside: +1.06%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.44
Upside: -41.86%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $42 → $43
Current: $46.94
Upside: -8.39%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $62.95
Upside: +8.02%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $39.11
Upside: -2.84%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $29.70
Upside: +11.11%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $127.55
Upside: +120.31%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $398.62
Upside: -45.56%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $236.64
Upside: -91.55%